Open AccessS1190 Hepatic Fibrosis Improvement Does Not Differ Between Type of Antiviral Therapy in Chronic Hepatitis B Patients
Author(s) -
Quynh-An Phan,
Ana Romero,
Sadde Mohamed,
Natalie Nguyen,
Miriam M. Sanchez,
Chukwuma Egwim,
Victor AnkomaSey
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000778292.21094.e3
Subject(s) - medicine , entecavir , tenofovir alafenamide , gastroenterology , fibrosis , hepatitis b , hbeag , pacific islanders , hepatitis b virus , immunology , hbsag , viral load , virus , lamivudine , population , environmental health , antiretroviral therapy